Founded in 2020, Aurora Tele-Oncology Limited (ATO) is a MedTech company which focuses on oncology-specialised telemedicine in Greater China market.
ATO’s mission is optimising cancer care through a virtual platform vision. The company strives to revolutionise the delivery of cancer care by breaking locational barriers. Patients not only can consult oncology experts worldwide, but also gain rapid access to novel treatment options and appropriate global clinical trials.
ATO has presence in Hong Kong, Wuxi and Shenzhen to build up a comprehensive cancer care ecosystem with global vision and international standard spanning across the Guangdong-Hong Kong-Macao Greater Bay Area and Yangtze River Delta.
